Nuwellis Approves 1-for-35 Reverse Stock Split, Effective June 25, to Avoid Delisting
Summary
Nuwellis approved a 1-for-35 reverse stock split on June 16, set to become effective June 25 with adjusted trading starting June 26. This follows an 8-K filed yesterday announcing the split and a series of highly dilutive capital raises and a 'going concern' warning in recent months. The aggressive 1-for-35 ratio underscores the company's severe financial distress and urgent need to boost its share price to maintain its Nasdaq listing. Reverse splits are typically a last resort for companies trading at penny stock levels and often precede further price erosion. The market's reaction to the split-adjusted trading on June 26 will be a key indicator of investor confidence.
At the time of this announcement, NUWE was trading at $0.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6M. The 52-week trading range was $0.12 to $25.95. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Reuters.